new substantial holder, page-11

re: looking good for 2006 Launch of scilin (insulin) product is due this month in Philippines. Soon after that, in Thailand. Pol


09:11, Monday, 14 November 2005

Sydney - Monday - November 14: (RWE Australian Business News) -
SciGen Ltd (ASX code: SIE) has received a licence to market its insulin
product SciLin in the Kingdom of Thailand.
According to the World Health Organisation, more than 3.5
Million Thais are diagnosed with diabetes and a large number of the
population remains undiagnosed.
The insulin pharmaceutical market in Thailand is estimated to be
$US15 million.
This market is presently shared by two multinational companies.
Preparations are under way for the launch of SciLin in Thailand
early next year.
SciLin is currently registered and sold by SciGen or its
partners in India, Vietnam and Pakistan, and will soon be launched in
the Philippines.
Shares in SciGen fell 0.1c to 7.2c on Friday.
ENDS